Assembly Biosciences, Inc. (ASMB): Price and Financial Metrics
ASMB Price/Volume Stats
| Current price | $15.02 | 52-week high | $19.93 |
| Prev. close | $15.34 | 52-week low | $7.69 |
| Day low | $14.60 | Volume | 19,200 |
| Day high | $15.34 | Avg. volume | 23,541 |
| 50-day MA | $16.63 | Dividend yield | N/A |
| 200-day MA | $14.65 | Market Cap | 95.47M |
ASMB Stock Price Chart Interactive Chart >
Assembly Biosciences, Inc. (ASMB) Company Bio
Assembly Biosciences develops oral therapies for intractable infectious diseases in the United States. The company focuses on the hepatitis B virus and C. difficile-associated infections. The company was founded in 2005 and is based in New York, New York.
ASMB Price Returns
| 1-mo | -10.54% |
| 3-mo | 2.81% |
| 6-mo | -0.40% |
| 1-year | 93.37% |
| 3-year | -44.37% |
| 5-year | -91.12% |
| YTD | 52.62% |
| 2023 | -36.92% |
| 2022 | -44.21% |
| 2021 | -61.49% |
| 2020 | -70.43% |
| 2019 | -9.55% |
Continue Researching ASMB
Want to see what other sources are saying about Assembly Biosciences Inc's financials and stock price? Try the links below:Assembly Biosciences Inc (ASMB) Stock Price | Nasdaq
Assembly Biosciences Inc (ASMB) Stock Quote, History and News - Yahoo Finance
Assembly Biosciences Inc (ASMB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...